InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Schallenberger Mark A.. Director active across 1 company, notably Xtant Medical Holdings, Inc.. Aggregated, 8 reports have been logged. Activity tracked since 15 February 2023. The latest transaction was disclosed on 15 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Schallenberger Mark A. is a declarant with 4 filings in total. The 4 sampled filings concern Xtant Medical Holdings, Inc., where he is Chief Operations Officer, and cover the period from 2023-02-17 to 2025-01-17. The reported buy and sell amounts for these recent filings are 0, and the modal transaction nature is Attribution.